Reading path
How to Read Brain and Nervous System Evidence
Brain and nervous system evidence leans on things that are hard to pin down: a diagnosis assembled from criteria, an image read for subtle change, a symptom scored on a scale. This path walks you through real appraisals so you can tell what a neurologic test, scan, or trial endpoint actually establishes. By the end you will be able to read a brain study and see clearly where its certainty ends.
The path, step by step
Start where many neurologic cases start, with how a diagnosis gets built from criteria that stitch together imaging and spinal-fluid markers rather than one definitive test.
See how a set of diagnostic criteria becomes a quick bedside test, and why its accuracy figures depend heavily on who is doing the assessing.
Move to a blood biomarker and practice the discipline of asking what a positive result confirms and, just as important, what it cannot tell you yet.
Bring imaging into the picture through the brain scans that monitor safety during amyloid therapy, where the finding itself changes what happens next.
This is the center of the path, where you learn to weigh a trial's endpoint against the harder question of whether the measured change is large enough to matter to a person.
Widen that skill to the rating scales behind much of brain and mental-health research, and see why the cutoff for a meaningful difference is genuinely debated.
Read a trial that found no winner among three seizure drugs, and learn why a well-built null comparison is an answer rather than a failure.
Watch imaging move from description to decision, selecting which stroke patients still benefit from treatment well past the old clock.
Close by weighing benefit against bleeding harm inside a time-limited treatment window, the balance every careful reader of brain evidence has to hold.
Each step is a full article on the Reading the Evidence blog.